Dechra Pharmaceuticals plc using EPIC/TICKER code (LON:DPH) has had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘OVERWEIGHT’ today by analysts at JP Morgan Cazenove. Dechra Pharmaceuticals plc are listed in the Health Care sector within UK Main Market. JP Morgan Cazenove have set their target price at 3200 GBX on its stock. This is indicating the analyst believes there is a potential upside of 15.5% from the opening price of 2770 GBX. Over the last 30 and 90 trading days the company share price has decreased 104 points and increased 204 points respectively. The 52 week high for the share price is currently at 3090 GBX while the year low stock price is currently 2030 GBX.
Dechra Pharmaceuticals plc has a 50 day moving average of 2,731.26 GBX and the 200 Day Moving Average price is recorded at 2,781.13. There are currently 102,878,460 shares in issue with the average daily volume traded being 324,061. Market capitalisation for LON:DPH is £2,940,286,982 GBP.
